Long-term outcome of ketoconazole and tacrolimus co-administration in kidney transplant patients

Table 1 Demographic characteristics of transplant patients between Group 1 (with ketoconazole) and Group 2 (without ketoconazole)

	Group 1(n = 199)	Group 2(n = 149)	P value
Age, mean ± SD (yr)	47.2 ± 13.2	48.8 ± 14.4	0.21
Gender (%)
Male	56	61	0.47
Female	44	39
Race (%)
Black	64	55	0.19
Non-black	36	45
BMI (kg/m2)	28.3 ± 5.4	27.4 ± 5.7	0.34
Peak PRA (%)	15.5 ± 25.3	13.8 ± 27.0	0.27
HLA mismatch	4.1 ± 1.4	3.9 ± 1.6	0.52
Causes of ESRD (%)			0.75
Diabetes	25	31
Hypertension	38	35
Nephritis	19	15
PCKD	8	6
Others	10	13
Induction (%)	55	51	0.51
Donors (%)			0.63
Living	26	29
Deceased	74	71
CIT (h)	17.8 ± 7.2	18.5 ± 6.4	0.24

SD: Standard deviation; BMI: Body mass index; PRA: Panel reactive antibodies; HLA: Human leukocyte antigen; ESRD: End stage renal disease; PCKD: Polycystic kidney disease.